Medicinal Cannabis Doesn’t Help Anxiety, Depression, or PTSD, Huge Review Finds
A large systematic review found limited evidence for cannabis in treating mental health disorders such as anxiety, depression, and PTSD. This challenges the widespread use of medicinal cannabis for these psychiatric conditions. Clinicians should…
First medical cannabis dispensary opening in Alabama in May – Yahoo
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic AccessPolicyState ProgramsChronic…
Once a Global Leader, Canada Restricts Medical Cannabis Access for Veterans
Canada medical cannabis access veterans policy is shifting, restricting treatment options for PTSD and chronic pain. Veterans face new barriers despite evidence supporting cannabinoids. Clinicians must navigate evolving regulations to support veteran…
Alabama Medical Cannabis Sales to Start in May – MJBizDaily
The Alabama medical cannabis program oversight will commence as sales start in May 2024. This oversight ensures patient access and regulatory compliance for qualifying conditions. Alabama expands treatment options with a structured medical cannabis…
Connecticut Senate Votes To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval
Connecticut psychedelics pilot program expansion marks a proactive step toward integrating psychedelic-assisted therapies. The state is establishing regulatory frameworks ahead of FDA approval for psilocybin and MDMA. This pilot program aims to improve…
Connecticut Lawmakers Vote to Expand Psilocybin Mushrooms for PTSD Treatment – MSN
Connecticut lawmakers have voted to expand access to psilocybin mushrooms for PTSD treatment, reflecting new policy developments. This expansion highlights the growing interest in psilocybin mushrooms for PTSD treatment as a potential option for patients…
Largest-ever Psychedelics Study Could Advance Use in Treating Mental Health Disorders
The largest psychedelic research mental health study marks a critical step toward evidence-based psychiatric care. This large-scale study aims to identify which patients benefit most from psychedelics. It could establish standardized protocols for…
Here’s What Psychedelics Actually Do to the Brain
Psychedelics neuropharmacology mental health research is advancing as these compounds enter clinical trials for treatment-resistant conditions. Understanding their brain effects is crucial for clinicians counseling patients. This emerging field offers…
Cresco Labs Joins Texas Medical Cannabis Program
Cresco Labs has been awarded a license in the Texas medical cannabis program, which restricts products to low THC levels. This expansion may improve patient access to standardized cannabis products. However, the program's narrow qualifying conditions…
Can Memory Loss Be Good? How Cannabis Helps with PTSD
Cannabis and PTSD treatment offer promising benefits, especially through cannabis-induced memory loss. This memory loss can help reduce the impact of traumatic memories. Many patients find cannabis helpful in managing PTSD symptoms.